Correction to Lancet Oncol 2022; 23: e450–58

Lorentzen CL, Haanen JB, Met Ö, Svane IM. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Lancet Oncol 2022; 23: e450–58—In this Review, the title of table 2 has been corrected. Abbreviations and headers in tables 1, 2, and 3 have been corrected. The last sentence in the first paragraph of the mRNA-based lipoplex vaccines section has been corrected to “Ongoing mRNA lipoplex vaccine trials are listed in table 1. Clinical trial results are listed in table 3.” Small typographical corrections have been made throughout the text. These corrections have been made as of Oct 7, 2022.